Avid Bioservices Inc (CDMO)

[John R]

Sorry about that I wasn't able to complete the post and sent the uncompleted version in error. Here is my full post, with a little editorialization on my part....

link for SEC 8K filing instructions...

https://www.sec.gov/about/forms/form8-k.pdf

I did not see clinical trial status specifically mentioned but believe it would be considered in section 8 but at the registrants option. I did a cursory google search and found biotechs/pharmas have filed 8k's for completion of enrollment previously.
Which begs my question.....why? Why would a development stage biotech company which has dropped 50% in past year not want to publicize the completion of enrollment in their first Ph III clinical trial of their flagship drug???

I'm open to responses on that. I hear frustration through my financial industry friends...."this is some of the best science out there but also the worst management out there".


Management has lost a lot of credibility on the street. Science can only get you so far at some point management has to actually kick in its share.



Section 8 - Other Events
Item 8.01 Other Events.
The registrant may, at its option, disclose under this Item 8.01 any events, with respect to which information is not otherwise called for
by this form, that the registrant deems of importance to security holders. The registrant may, at its option, fi le a report under this Item
8.01 disclosing the nonpublic information required to be disclosed by Regulation FD (17 CFR 243.100 through 243.103).ere is the